Skip to content
10-Q

Quarterly Report

Janux Therapeutics, Inc. JANX

0000950170-25-105069

← back to feed
Filed
Aug 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 5, 2025 60.09M sh
Shares Diluted Q2 2025 · Jun 30, 2025 61.9M sh
Shares Diluted Q2 2025 · Jun 30, 2025 61.85M sh
Shares Diluted Q2 2025 · Jun 30, 2024 54.45M sh
Shares Diluted Q2 2025 · Jun 30, 2024 51.75M sh
Capex Q2 2025 · Jun 30, 2025 $844K
Capex Q2 2025 · Jun 30, 2024 $292K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$40.84M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$24.86M
Short Term Investments Q2 2025 · Jun 30, 2025 $943.57M
Short Term Investments Q2 2025 · Dec 31, 2024 $594.57M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $52.45M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $430.61M
Stockholders Equity Q2 2025 · Jun 30, 2025 $990.52M
Stockholders Equity Q2 2025 · Mar 31, 2025 $1.01B
Stockholders Equity Q2 2025 · Dec 31, 2024 $1.02B
Stockholders Equity Q2 2025 · Jun 30, 2024 $657.68M
Stockholders Equity Q2 2025 · Mar 31, 2024 $655.76M
Stockholders Equity Q2 2025 · Dec 31, 2023 $344.35M
Current Liabilities Q2 2025 · Jun 30, 2025 $21.38M
Current Liabilities Q2 2025 · Dec 31, 2024 $17.46M
Total Liabilities Q2 2025 · Jun 30, 2025 $41.7M
Total Liabilities Q2 2025 · Dec 31, 2024 $38.74M
Current Assets Q2 2025 · Jun 30, 2025 $1.01B
Current Assets Q2 2025 · Dec 31, 2024 $1.03B
Total Assets Q2 2025 · Jun 30, 2025 $1.03B
Total Assets Q2 2025 · Dec 31, 2024 $1.06B
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.55
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.93
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.11
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.40
Eps Basic Q2 2025 · Jun 30, 2025 −$0.55
Eps Basic Q2 2025 · Jun 30, 2025 −$0.93
Eps Basic Q2 2025 · Jun 30, 2024 −$0.11
Eps Basic Q2 2025 · Jun 30, 2024 −$0.40
Sga Expense Q2 2025 · Jun 30, 2025 $10.45M
Sga Expense Q2 2025 · Jun 30, 2025 $20.3M
Sga Expense Q2 2025 · Jun 30, 2024 $7.82M
Sga Expense Q2 2025 · Jun 30, 2024 $15.16M
Rd Expense Q2 2025 · Jun 30, 2025 $34.66M
Rd Expense Q2 2025 · Jun 30, 2025 $59.72M
Rd Expense Q2 2025 · Jun 30, 2024 $14.9M
Rd Expense Q2 2025 · Jun 30, 2024 $28.97M
Net Income Q2 2025 · Jun 30, 2025 −$33.86M
Net Income Q2 2025 · Jun 30, 2025 −$57.37M
Net Income Q2 2025 · Jun 30, 2024 −$5.96M
Net Income Q2 2025 · Jun 30, 2024 −$20.72M
Operating Income Q2 2025 · Jun 30, 2025 −$45.12M
Operating Income Q2 2025 · Jun 30, 2025 −$80.02M
Operating Income Q2 2025 · Jun 30, 2024 −$13.82M
Operating Income Q2 2025 · Jun 30, 2024 −$33.98M
Revenue Q2 2025 · Jun 30, 2025 $0
Revenue Q2 2025 · Jun 30, 2025 $0
Revenue Q2 2025 · Jun 30, 2024 $8.9M
Revenue Q2 2025 · Jun 30, 2024 $10.15M